Novo Nordisk to cut price of Wegovy amid rising weight-loss drug competition
Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival Eli Lilly discounted some of its Zepbound injections last week. The Danish drugmaker will sell Wegovy directly to patients through its own online pharmacy.
By Sriparna Roy (Reuters) -Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli ...
5mon MSN
Novo Nordisk’s GLP-1 drug Semaglutide, sold under brand names Ozempic and Wegovy, has been hailed as a miracle drug for ...
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback